Monopar Therapeutics Inc (MNPR) financials · $431.4M cap
Monopar Therapeutics Inc (MNPR) $431.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$16.7M | -$16.2M |
| Net Income | -$13.7M | -$15.6M |
| EPS (Diluted) | $0.00 | $0.00 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $140.7M | $60.3M |
| Current Assets | $140.5M | $60.3M |
| Cash & Equivalents | $61.8M | $45.8M |
| Inventory | $0 | $0 |
| PP&E | $0 | $0 |
| Total Liabilities | $2.9M | $5.3M |
| Current Liabilities | $2.7M | $5.3M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $137.8M | $55.0M |
| Retained Earnings | -$89.5M | -$75.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.2M | -$6.4M |
| CapEx | $0 | $0 |
| Investing Cash Flow | -$63.5M | -$14.3M |
| Financing Cash Flow | $91.6M | $59.3M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $16.0M | $0 |
| Free Cash Flow | $0 | $0 |
FAQ
What is MNPR P/E and revenue?
Monopar Therapeutics Inc (MNPR) $431.4M cap.
What is MNPR revenue?
Monopar Therapeutics Inc last cached revenue is $0 (FY2025).
Is MNPR profitable?
Monopar Therapeutics Inc last cached net income is -$13.7M.
What are MNPR total assets?
Monopar Therapeutics Inc last cached total assets are $140.7M.
What is MNPR free cash flow?
Monopar Therapeutics Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.